Naturalendo Tech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 2.32%

Naturalendo Tech Co Ltd (168330) has an Asset Resilience Ratio of 2.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩829.03 Million

≈ $561.82K USD Cash + Short-term Investments

Total Assets

₩35.70 Billion

≈ $24.20 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Naturalendo Tech Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Naturalendo Tech Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Naturalendo Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Naturalendo Tech Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩829.03 Million	2.32%
Total Liquid Assets	₩829.03 Million	2.32%

Asset Resilience Insights

Limited Liquidity: Naturalendo Tech Co Ltd maintains only 2.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Naturalendo Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Naturalendo Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Genfit S.A. PA:GNFT	Biotechnology	64.01%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	22.98%
Altimmune Inc NASDAQ:ALT	Biotechnology	82.06%
Clarity Pharmaceuticals Ltd AU:CU6	Biotechnology	73.99%
Jiangsu GDK Biotechnology Co Ltd SHG:688670	Biotechnology	9.82%

Annual Asset Resilience Ratio for Naturalendo Tech Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Naturalendo Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.78%	₩995.27 Million ≈ $674.48K	₩35.83 Billion ≈ $24.28 Million	+2.67pp
2024-12-31	0.11%	₩35.79 Million ≈ $24.26K	₩33.34 Billion ≈ $22.59 Million	-7.45pp
2023-12-31	7.56%	₩2.81 Billion ≈ $1.91 Million	₩37.20 Billion ≈ $25.21 Million	-7.61pp
2022-12-31	15.17%	₩6.04 Billion ≈ $4.09 Million	₩39.81 Billion ≈ $26.98 Million	+15.17pp
2017-12-31	0.00%	₩50.00 ≈ $0.03	₩85.68 Billion ≈ $58.07 Million	-17.47pp
2016-12-31	17.47%	₩15.00 Billion ≈ $10.17 Million	₩85.88 Billion ≈ $58.20 Million	+15.21pp
2014-12-31	2.25%	₩2.00 Billion ≈ $1.36 Million	₩88.72 Billion ≈ $60.12 Million	--

pp = percentage points

About Naturalendo Tech Co Ltd

KQ:168330 Korea Biotechnology

Market Cap

$38.73 Million

₩57.15 Billion KRW

Market Cap Rank

#22832 Global

#1468 in Korea

Share Price

₩1810.00

Change (1 day)

+4.14%

52-Week Range

₩1738.00 - ₩1919.00

All Time High

₩1919.00